Literature DB >> 1743358

The role of penetrating keratoplasty in the management of microbial keratitis.

C M Kirkness1, L A Ficker, A D Steele, N S Rice.   

Abstract

Penetrating keratoplasty was performed as an emergency procedure in 52 eyes which had perforated from acute microbial keratitis and in a further 11 where perforation had not yet occurred. The results are compared with those of keratoplasty in 33 non-infected perforations and 20 eyes where there had been microbial keratitis which had responded to medical therapy leaving a scarred cornea. This latter group had both a better five year survival (90%) compared to all the others (51%), p less than 0.05, and achieved significantly better visual acuities, p less than 0.005.

Entities:  

Mesh:

Year:  1991        PMID: 1743358     DOI: 10.1038/eye.1991.68

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  5 in total

1.  Strategies for the management of microbial keratitis.

Authors:  B D Allan; J K Dart
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

2.  Rose Bengal Photodynamic Antimicrobial Therapy: A Novel Treatment for Resistant Fusarium Keratitis.

Authors:  Guillermo Amescua; Alejandro Arboleda; Neda Nikpoor; Heather Durkee; Nidhi Relhan; Mariela C Aguilar; Harry W Flynn; Darlene Miller; Jean-Marie Parel
Journal:  Cornea       Date:  2017-09       Impact factor: 2.651

3.  Clear graft survival and immune reactions following emergency keratoplasty.

Authors:  P Maier; D Böhringer; T Reinhard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-06       Impact factor: 3.117

Review 4.  Recent Advances in Photodynamic Therapy against Fungal Keratitis.

Authors:  Jia-Horung Hung; Chaw-Ning Lee; Huai-Wen Hsu; I-Son Ng; Chi-Jung Wu; Chun-Keung Yu; Nan-Yao Lee; Yun Chang; Tak-Wah Wong
Journal:  Pharmaceutics       Date:  2021-11-26       Impact factor: 6.321

5.  Incidence and risk factors for post-penetrating keratoplasty glaucoma.

Authors:  Neha Shree; Monica Gandhi; Abhishek Dave; Umang Mathur
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.